Literature DB >> 17876007

Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.

Joshua S Hawley, Clinton K Murray, James H Jorgensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876007      PMCID: PMC2168019          DOI: 10.1128/AAC.01115-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

1.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Cationic antimicrobial peptide resistance in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; Karita D Ambrose; Susu Zughaier; Xiaoliu Zhou; Yoon K Miller; William M Shafer; David S Stephens
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

3.  Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants.

Authors:  F Van Bambeke; M Chauvel; P E Reynolds; H S Fraimow; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.

Authors:  Joshua S Hawley; Clinton K Murray; Matthew E Griffith; M Leticia McElmeel; Letitia C Fulcher; Duane R Hospenthal; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

5.  Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth.

Authors:  H S Fraimow; D L Jungkind; D W Lander; D R Delso; J L Dean
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

6.  In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates.

Authors:  Roxanne J Owen; Jian Li; Roger L Nation; Denis Spelman
Journal:  J Antimicrob Chemother       Date:  2007-02-08       Impact factor: 5.790

7.  Nosocomial infection with vancomycin-dependent enterococci.

Authors:  Paul A Tambyah; John A Marx; Dennis G Maki
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

  7 in total
  10 in total

1.  Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections.

Authors:  James M Regeimbal; Anna C Jacobs; Brendan W Corey; Matthew S Henry; Mitchell G Thompson; Rebecca L Pavlicek; Javier Quinones; Ryan M Hannah; Meron Ghebremedhin; Nicole J Crane; Daniel V Zurawski; Nimfa C Teneza-Mora; Biswajit Biswas; Eric R Hall
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Bacterial flora of combat wounds from eastern Ukraine and time-specified changes of bacterial recovery during treatment in Ukrainian military hospital.

Authors:  Kovalchuk P Valentine; Kondratiuk M Viacheslav
Journal:  BMC Res Notes       Date:  2017-04-07

Review 3.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

Review 4.  Efficacy and safety of polymyxins for the treatment of Acinectobacter baumannii infection: a systematic review and meta-analysis.

Authors:  Qianqian Liu; Wenzhang Li; Yulin Feng; Chuanmin Tao
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

5.  Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection.

Authors:  Zhijin Chen; Yu Chen; Yaogao Fang; Xiaotian Wang; Yanqing Chen; Qingsong Qi; Fang Huang; Xungang Xiao
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

6.  Transition of colistin dependence into colistin resistance in Acinetobacter baumannii.

Authors:  Ji-Young Lee; Eun Seon Chung; Kwan Soo Ko
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

7.  Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.

Authors:  H Nordqvist; L E Nilsson; C Claesson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-10       Impact factor: 3.267

8.  Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance.

Authors:  Yan Zhu; Jing Lu; Mei-Ling Han; Xukai Jiang; Mohammad A K Azad; Nitin A Patil; Yu-Wei Lin; Jinxin Zhao; Yang Hu; Heidi H Yu; Ke Chen; John D Boyce; Rhys A Dunstan; Trevor Lithgow; Christopher K Barlow; Weifeng Li; Elena K Schneider-Futschik; Jiping Wang; Bin Gong; Bjorn Sommer; Darren J Creek; Jing Fu; Lushan Wang; Falk Schreiber; Tony Velkov; Jian Li
Journal:  Adv Sci (Weinh)       Date:  2020-06-08       Impact factor: 16.806

9.  Interplay of Klebsiella pneumoniae fabZ and lpxC Mutations Leads to LpxC Inhibitor-Dependent Growth Resulting from Loss of Membrane Homeostasis.

Authors:  Mina Mostafavi; Lisha Wang; Lili Xie; Kenneth T Takeoka; Daryl L Richie; Fergal Casey; Alexey Ruzin; William S Sawyer; Christopher M Rath; Jun-Rong Wei; Charles R Dean
Journal:  mSphere       Date:  2018-10-31       Impact factor: 4.389

10.  Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates.

Authors:  Hadas Kon; Amichay Hameir; Elizabeth Temkin; Alona Keren-Paz; David Schwartz; Vered Schechner; Yehuda Carmeli
Journal:  Microorganisms       Date:  2021-12-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.